The transaction, structured as a stock-heavy merger, grants Tempus the discretion to settle up to 50% of the consideration in cash. Shareholders are set to receive a floating exchange ratio of Tempus common stock, capped at 0.3356 shares for every Personalis share held at closing. Ademi LLP alleges that the agreement includes restrictive provisions, specifically a penalty mechanism that discourages Personalis from entertaining alternative acquisition bids.

Beyond valuation concerns, the investigation focuses on the board’s conduct regarding change-of-control arrangements. Ademi LLP claims that Personalis insiders stand to receive significant benefits from the merger, raising questions about whether directors prioritized these personal gains over the interests of public shareholders. The firm is currently soliciting feedback from investors to determine if the board failed its legal obligation to secure the most favorable outcome for all stakeholders.